Prof. Daniel Kelly is a Principal Investigator in the Trinity Centre for Biomedical Engineering. His research focuses on developing novel approaches to regenerating damaged and diseased musculoskeletal tissues. He investigates how the physical and chemical properties of a biomaterial, as well as the therapeutic factors it delivers, determines the host response to such an implant. The aim is develop the next generation of implants targeting specific clinical problems in orthopaedic and cardiovascular medicine.
Prof. Kelly is a four-time ERC awardee and recipient of numerous other awards. He is Professor of Tissue Engineering and a co-leads the Materials for Health theme at AMBER with Prof. Fergel O’Brien. This extends their successful work in regenerative medicine combining innovative scaffold systems with therapeutics to address important problems. The work spans 3D printing of next-generation scaffolds for orthopaedic repair to advanced systems for nanomedicine delivery and novel electroconductive systems to address infarcted heart muscle and restore functionality to damaged nerves.
Prof Kelly is also the academic lead of the TRANSITION spoke programme, a collaboration between AMBER, DePuy Ireland Unlimited Company and Johnson & Johnson Services, Inc. The aim of this project is to develop a new class of 3D-printed biological implant that will regenerate, rather than replace, diseased joints.
AMBER has a strong emphasis on collaboration. Central to AMBER’s research remit are collaborative projects performed with industry partners, and working with academic, industry and wider stakeholder on international and national research programmes.Get in touch